Similar companies
Income Statement (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Revenue | 159M | 13% |
| Gross Profit | 119M | 14.3% |
| Cost of Revenue | 40M | 9.2% |
| Operating expense | 148M | 42% |
| Net Income | 32M | 28.8% |
Balance Sheet (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Total Assets | 1.12B | 6.4% |
| Total Liabilities | 80M | 10.7% |
| Total Equity | 1.04B | 8% |
| Shares Outstanding | 165M | 1.8% |
Cash Flow (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Cash from operations | 11M | 73.5% |
| Cash from financing | 390,000 | 93.2% |
EPS
Financial Highlights for Astera Labs in Q1 '25
Astera Labs reported a revenue of 159M, which is a 13% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 119M, marking a 14.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 40M, a 9.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 148M, showing a 42% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 32M, showing a 28.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
It was a positive quarter for Astera Labs with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
